Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Viale

Showing results (241-250 of 302) with videos related to

Pageof 31
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 27, 2009
The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-upM Colleoni, Z Sun, G Martinelli, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 10, 2016
Sentinel node biopsy after neoadjuvant treatment in breast cancer: Five-year follow-up of patients with clinically node-negative or node-positive disease before treatmentV Galimberti, S K Ribeiro Fontana, P Maisonneuve, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 29, 2020
The legacy of Professor Aron GoldhirschR D Gelber, A S Coates, S Gelber, et al.
Breast Cancer Research and Treatment|June 30, 2009
Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedureE Montagna, G Viale, N Rotmensz, et al.
Leukemia|February 19, 2011
The self-association coiled-coil domain of PML is sufficient for the oncogenic conversion of the retinoic acid receptor (RAR) alphaM Occhionorelli, F Santoro, I Pallavicini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 6, 2007
Patients with advanced stage breast carcinoma immunoreactive to biotinylated Herceptin are most likely to benefit from trastuzumab-based therapy: an hypothesis-generating studyA Sapino, F Montemurro, C Marchiò, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 2011
Outcome of special types of luminal breast cancerM Colleoni, N Rotmensz, P Maisonneuve, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2011
Breast cancer subtypes and outcome after local and regional relapseE Montagna, V Bagnardi, N Rotmensz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2011
Should liver metastases of breast cancer be biopsied to improve treatment choice?G Curigliano, V Bagnardi, G Viale, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2008
p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancerA Ravaioli, F Monti, M M Regan, et al.
Pageof 31

Showing results (241-250 of 302) with videos related to

Sort By:
Pageof 31
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 27, 2009
The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-upM Colleoni, Z Sun, G Martinelli, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 10, 2016
Sentinel node biopsy after neoadjuvant treatment in breast cancer: Five-year follow-up of patients with clinically node-negative or node-positive disease before treatmentV Galimberti, S K Ribeiro Fontana, P Maisonneuve, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 29, 2020
The legacy of Professor Aron GoldhirschR D Gelber, A S Coates, S Gelber, et al.
Breast Cancer Research and Treatment|June 30, 2009
Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedureE Montagna, G Viale, N Rotmensz, et al.
Leukemia|February 19, 2011
The self-association coiled-coil domain of PML is sufficient for the oncogenic conversion of the retinoic acid receptor (RAR) alphaM Occhionorelli, F Santoro, I Pallavicini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 6, 2007
Patients with advanced stage breast carcinoma immunoreactive to biotinylated Herceptin are most likely to benefit from trastuzumab-based therapy: an hypothesis-generating studyA Sapino, F Montemurro, C Marchiò, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 2011
Outcome of special types of luminal breast cancerM Colleoni, N Rotmensz, P Maisonneuve, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2011
Breast cancer subtypes and outcome after local and regional relapseE Montagna, V Bagnardi, N Rotmensz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2011
Should liver metastases of breast cancer be biopsied to improve treatment choice?G Curigliano, V Bagnardi, G Viale, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2008
p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancerA Ravaioli, F Monti, M M Regan, et al.
Pageof 31